Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Sernova Corp SEOVF


Primary Symbol: T.SVA

Sernova Corp. is a Canada-based clinical-stage biotechnology company, which is developing therapeutic cell technologies for chronic diseases, including insulin-dependent diabetes, thyroid disease, and blood disorders that include hemophilia A. The Company is focused on developing a functional cure for insulin-dependent diabetes with its therapeutic cell technology lead asset, the Cell Pouch... see more

Recent & Breaking News (TSX:SVA)

Sernova Announces $2,000,000 First Closing of Private Placement

MarketWire Canada June 27, 2016

Sernova Announces Non-Brokered Private Placement

MarketWire Canada June 21, 2016

Sernova Announces First Quarter Fiscal Year 2016 Financial Results and Provides Corporate Update

Marketwired March 15, 2016

Sernova Receives First Payment from the European Commission's Horizon 2020 Grant to Fund Development of a Cell-Based Hemophilia Therapeutic Using the Cell Pouch(TM)

Press Releases February 16, 2016

Sernova Honoured as Member of the "2016 TSX Venture 50" and Ranked #4 in Life Sciences and Clean Technologies

Marketwired February 5, 2016

Sernova Announces Agreement With CCRM to Produce Specialized Cells for the Treatment of Diabetes

Marketwired January 26, 2016

Sernova Corp to Present at the Biotech Showcase(TM) 2016 in San Francisco on January 13, 2016

Marketwired January 6, 2016

Sernova Awarded Europe's Prestigious Horizon 2020 Grant to Fund Development of Cell-Based Hemophilia Therapeutic Product Into the Clinic

Marketwired December 21, 2015

SeeThruEquity Initiates Coverage on Sernova Corp. (TSX: SVA, OTCQB: SEOVF) with a Price Target of CAD $0.76

Accesswire October 5, 2015

SeeThruEquity Initiates Coverage on Sernova Corp. (TSX: SVA, OTCQB: SEOVF) with a Price Target of CAD $0.76

Accesswire October 5, 2015

Sernova Announces Listing on OTCQB Exchange

Marketwired September 21, 2015

MicroCap Report: Cardiff Energy (V.CRS) fixes up, Sernova Corp (V.SVA) sees sell-off

Stockhouse Editorial September 10, 2015

Sernova Secures Commercial Rights to Proprietary Stem Cell Derived Technologies

Marketwired September 10, 2015

Sernova Corp. Announces Collaboration with Massachusetts General Hospital to Develop Novel Diabetes Treatment with Funding Support from JDRF

Marketwired July 7, 2015

Sernova Grants Stock Options

Marketwired June 26, 2015

Sernova Completes Oversubscribed Private Placement; Adds Management Depth With New CFO

Marketwired May 15, 2015

Sernova Announces Non-Brokered Private Placement

Marketwired May 8, 2015

Sernova Receives Issued Patent in the United States for Its Cell Pouch(TM) and Therapeutic Cell Transplantation Technologies

Marketwired April 23, 2015

Sernova Announces Annual Meeting and Nominees for Its Board of Directors

Marketwired March 5, 2015

Sernova is Awarded Patents in Multiple Countries for Cell Pouch(TM) and Therapeutic Cell Transplantation Technologies

Marketwired February 12, 2015